我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

急性心肌梗死住院患者应用临床路径的效果评价(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2012年第1期
页码:
46-49
栏目:
临床研究
出版日期:
2012-02-25

文章信息/Info

Title:
Assessment of the clinical pathway effect for acute myocardial infarction
作者:
拓 文孙 敏徐 楷邢尔克郭 宏张会军梁泽民
(宝鸡市心血管病诊治中心、宝鸡市中医医院心内二科,陕西 宝鸡 721001)
Author(s):
TUO Wen SUN Min XU Kai XING Er-ke GUO Hong ZHANG Hui-jun LIANG Ze-min
(Baoji Cardiology Center of Diagnosis and Treatment, Baoji Hospital of Traditional Chinese Medicine, Baoji 721001, Shaanxi, China)
关键词:
心肌梗死急性临床路径早期再灌注治疗住院时间病死率
Keywords:
AMI clinical pathway early reperfusion therapy hospitalization days survival
分类号:
R541.4
DOI:
-
文献标识码:
A
摘要:
目的:评价在急性心肌梗死(AMI)住院患者诊治中应用临床路径的效果。方法: 根据ACC/AHA及中国急性冠脉综合征诊治指南制定我院AMI临床路径,并将临床路径附在病例中,每6 个月对关键环节执行情况进行一次评估,并对数据进行分析,提出改进措施。以我院心内科住院AMI患者为研究对象,临床路径应用前收集2006年10月~2008年3月住院AMI患者76(男54,女22)例,年龄(63±12)岁,作为应用前对照组(应用前组);应用临床路径后连续收集2008年4月~2009年9月住院AMI患者98(男74,女24)例,年龄(62±12)岁,作为临床路径应用组(应用组)。结果: 临床路径应用组AMI患者住院时间较应用前明显缩短,其中急性ST抬高心肌梗死患者住院天数[(13±8)d vs.(9±7)d,P<0.05],急性非ST抬高心肌梗死患者住院时间[(13±7)d vs.(7±9)d,P<0.05];应用后高危患者接受冠脉造影率为78%,较应用前(48%)显著提高(P<0.01);应用后急性ST抬高心肌梗死患者入院到球囊扩张时间(D-B时间)较应用前显著下降(P<0.01);12 h内到达医院的ST抬高心肌梗死患者中早期再灌注治疗率临床路径应用前后分别为67%和87%(P<0.05);AMI药物规范治疗方面,应用后联合用药明显提高;干预后AMI患者住院期间病死率较应用前显著下降(12% vs. 2%,P<0.05)。结论: 在 AMI住院患者中应用临床路径进行诊疗可显著改善医疗质量,提高临床疗效,缩短住院时间。
Abstract:
AIM:To optimize the diagnosis and treatment process, narrow the gap between clinical medicine and evidence-based medicine, improve the quality of diagnosis and treatment, reduce medical expenses, use limited medical service resources reasonably and offer patients the highest benefit. METHODS: According to ACC/AHA and Chinese acute coronary syndrome diagnosis and treatment guidelines, we developed our AMI clinical pathway and implemented its use in our hospital. Every 6 months an evaluation of the clinical pathway implemented was conducted in 76 AMI patients (admitted from October 2006 to March 2008) as a baseline before the implementation and 98 AMI patients (admitted from April 2008 to September 2009) after the implementation. RESULTS: After implementation of the clinical pathway, hospitalization time was significantly shortened, with a 3.5-day reduction in ST segment elevation myocardial infarction (STEMI) patients and 6.14-day reduction in non-STEMI patients (P<0.05). The rate of high-risk patients undergoing coronary angiography increased from 48% to 78% (P<0.01), whereas the “door-to balloon” (DB) time of STEMI patients decreased by 43% (P<0.01). The rate of early reperfusion in STEMI patients arriving at the hospital within 12 h was enhanced from 67% to 87%, combined use of ACEI/ARB markedly increased (P<0.05) and mortality rate in AMI patients decreased by 9.8% (P<0.05). CONCLUSION: Implementation of the clinical pathway for AMI patients greatly reduces hospitalization days, decreases DB time, increases proportion of emergency PCI for STEAMI patients and significantly reduces mortality rate.

参考文献/References

[1]Murray CJ,Lopez AD.Regional patterns of disability-free life expectancy and disability-adjusted life expectancy:global Burden of Disease Study[J].Lancet,1997,3499(9062):1347-1352.

[2]Murry CJ,Lapez AD.Alternative projections of mortality and disability by cause1990-2020: Global Burden of Disease Study[J].Lancet,1997,349(9064):1498-1504.

[3]He J,Gu D,Wu X,et al.Major causes of death among men and women in China[J].New Engl J Med,2005,353(11):1124-1134.

[4]Cannon CP.Critical pathway for unstable angina and non-ST elevation myocardial infarction:February 2002[J].Crit Pathw Cardiol,2002,1(1):12-21.

[5]Bi Y,Gao R,Patel A,et al.Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1year after hospitalization:Results from the clinical Pathways for Acute Coronary Syndromes in China(CPACS) study[J].Am Heart J,2009,157(3):509-516.

备注/Memo

备注/Memo:
收稿日期:2011-03-21.作者简介:拓文,副主任医师 Email:dontw@163.com
更新日期/Last Update: 2012-02-14